Large-scale testing (Phase 3)Study completedNCT02242643
What this trial is testing
Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine (GSK2282512A) Compared to Fluzone® Quadrivalent in Children 6 to 35 Months of Age
Who this might be right for
Influenza
GlaxoSmithKline 2,432